# FDA recall D-0113-2017

> **Boehringer Ingelheim Pharmaceuticals, Inc.** · Class II · drug recall initiated 2016-10-06.

## Product

Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT  06877, NDC 0597-0019-01

## Reason for recall

Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and  50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0113-2017
- **Recalling firm:** Boehringer Ingelheim Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-10-06
- **Report date:** 2016-11-02
- **Termination date:** 2017-11-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ridgefield, CT, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0113-2017

## Citation

> AI Analytics. FDA recall D-0113-2017. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0113-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*